Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

Published 08/01/2024, 13:20
Updated 08/01/2024, 14:40
© Reuters.  Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
CYCC
-
SPR
-
NSTGQ
-
AMPE
-
HRTX
-
VMAR
-
HARP
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading.

LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.

LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Harpoon Therapeutics, Inc.(NASDAQ: HARP) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.
  • Vincerx Pharma, Inc. (NASDAQ: VINC) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma.
  • Spectaire Holdings Inc. (NASDAQ: SPEC) shares gained 46.6% to $2.48 in pre-market trading after gaining 7% on Friday.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares gained 36.5% to $3.40 in pre-market trading after jumping over 10% on Friday.
  • Vision Marine Technologies Inc. (NASDAQ: VMAR) shares climbed 30.4% to $1.24 in pre-market trading.
  • Heron Therapeutics, Inc. (NASDAQ: HRTX) shares rose 14.1% to $2.02 in pre-market trading. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.
  • Ampio Pharmaceuticals, Inc. (NYSE: AMPE) gained 12.4% to $2.00 in pre-market trading after falling around 8% on Friday.
  • NanoString Technologies, Inc. (NASDAQ: NSTG) shares rose 11.8% to $0.6060 in pre-market trading. NanoString's CosMx SMI achieved whole transcriptome imaging at single-cell resolution.
  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) gained 9.2% to $0.5799 in pre-market trading.
  • Heart Test Laboratories, Inc. (NASDAQ: HSCS) gained 8.8% to $0.1799 in pre-market trading. Heart Test Laboratories received decision to grant European Patent "Electrocardiogram-Based Assessment of Diastolic Function (Using Machine-Learned Computational Models).
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Banzai International, Inc. (NASDAQ: BNZI) shares fell 18.3% to $2.10 in pre-market trading. Banzai shares jumped around 55% on Friday after the company signed an LOI to acquire IGLeads.
  • The Arena Group Holdings, Inc. (NYSE: AREN) shares fell 17.2% to $1.78 in pre-market trading after dipping 17% on Friday.
  • Spirit AeroSystems Holdings, Inc. (NYSE: SPR) shares fell 16.4% to $26.53 in pre-market trading. The FAA ordered the temporary grounding of certain Boeing 737 Max 9 aircraft operated by U.S. Airlines or in U.S. territory.
  • Charge Enterprises, Inc. (NASDAQ: CRGE) shares fell 14.8% to $0.0793 in pre-market trading after dipping around 11% on Friday.
  • Safe and Green Development Corporation (NASDAQ: SGD) shares fell 14.3% to $1.74 in pre-market trading after jumping 49% on Friday.
  • Future FinTech Group Inc. (NASDAQ: FTFT) shares fell 13.4% to $1.23 in pre-market trading after dipping 22% on Friday.
  • Sharps Technology, Inc. (NASDAQ: STSS) fell 11.1% to $0.40 in pre-market trading after jumping 12% on Friday.
  • Ainos, Inc. (NASDAQ: AIMD) shares fell 11% to $2.44 in pre-market trading after jumping over 58% on Friday.
  • Brera Holdings PLC (NASDAQ: BREA) fell 10.1% to $0.6566 in pre-market trading.

Now Read This: Commercial Metals, Boot Barn And 3 Stocks To Watch Heading Into Monday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.